Lipocalin‐type prostaglandin D synthase‐derived PGD2 attenuates malignant properties of tumor endothelial cells

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of Pathology

• Publication date

  2017-11-10

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1002/path.4993PMID 29124765
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tumor angiogenesis

  2020cited by this paper
• Giemsa is the optimal counterstain for immunohistochemical detection of BRAF V600E mutation status in pigmented melanomas

  2016influential reference
• Inhibition of multidrug transporter in tumor endothelial cells enhances antiangiogenic effects of low-dose metronomic paclitaxel.

  2015cited by this paper
• PGD2 deficiency exacerbates food antigen-induced mast cell hyperplasia

  2015cited by this paper
• Opposing Immunomodulatory Roles of Prostaglandin D2 during the Progression of Skin Inflammation

  2014cited by this paper
• Tumor Endothelium FasL Establishes a Selective Immune Barrier Promoting Tolerance in Tumors

  2014cited by this paper
• Anti-inflammatory role of PGD2 in acute lung inflammation and therapeutic application of its signal enhancement

  2013cited by this paper
• Orally administered rubiscolin-6, a δ opioid peptide derived from Rubisco, stimulates food intake via leptomeningeal lipocallin-type prostaglandin D synthase in mice.

  2012cited by this paper
• Cyclooxygenase‐2 inhibition causes antiangiogenic effects on tumor endothelial and vascular progenitor cells

  2012cited by this paper
• TGF-β-induced mesenchymal transition of MS-1 endothelial cells requires Smad-dependent cooperative activation of Rho signals and MRTF-A.

  2012cited by this paper
• Tumor endothelial cells.

  2012cited by this paper
• A mouse model of the cornea pocket assay for angiogenesis study.

  2011cited by this paper
• Inflammation-induced endothelial-to-mesenchymal transition: a novel mechanism of intestinal fibrosis.

  2011influential reference
• Prostagladin D2 is a mast cell-derived antiangiogenic factor in lung carcinoma

  2011cited by this paper
• Aspirin use and survival after diagnosis of colorectal cancer.

  2009cited by this paper
• Tumor angiogenesis.

  2008cited by this paper
• Thromboxane A2 receptors in prostate carcinoma: expression and its role in regulating cell motility via small GTPase Rho.

  2008cited by this paper
• The role of endothelial-to-mesenchymal transition in cancer progression

  2008influential reference
• Role of prostaglandin D2 receptor DP as a suppressor of tumor hyperpermeability and angiogenesis in vivo

  2008cited by this paper
• Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts.

  2007influential reference
• Genes that distinguish physiological and pathological angiogenesis.

  2007cited by this paper
• Tumor endothelial cells express epidermal growth factor receptor (EGFR) but not ErbB3 and are responsive to EGF and to EGFR kinase inhibitors.

  2006cited by this paper
• Lipocalin-type prostaglandin D synthase produces prostaglandin D2 involved in regulation of physiological sleep

  2006cited by this paper
• Cardiac Ischemia Activates Vascular Endothelial Cadherin Promoter in Both Preexisting Vascular Cells and Bone Marrow Cells Involved in Neovascularization

  2006cited by this paper
• Activator Protein-1 Mediates Shear Stress–Induced Prostaglandin D Synthase Gene Expression in Vascular Endothelial Cells

  2005cited by this paper
• Role of prostaglandin E2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression.

  2004cited by this paper
• Murine Lewis lung carcinoma-derived endothelium expresses markers of endothelial activation and requires tumor-specific extracellular matrix in vitro.

  2003cited by this paper
• Host Prostaglandin E2-EP3 Signaling Regulates Tumor-Associated Angiogenesis and Tumor Growth

  2003cited by this paper
• Gene transfer of thromboxane A(2) synthase and prostaglandin I(2) synthase antithetically altered tumor angiogenesis and tumor growth.

  2002cited by this paper
• Significance of blood vessel leakiness in cancer.

  2002cited by this paper
• Prostaglandins and leukotrienes: advances in eicosanoid biology.

  2001cited by this paper
• Fluid shear stress induces lipocalin-type prostaglandin D(2) synthase expression in vascular endothelial cells.

  2000cited by this paper
• Genes expressed in human tumor endothelium.

  2000cited by this paper
• Fluid Shear Stress Induces Lipocalin-Type Prostaglandin D2 Synthase Expression in Vascular Endothelial Cells

  2000cited by this paper
• Lack of tactile pain (allodynia) in lipocalin-type prostaglandin D synthase-deficient mice.

  1999cited by this paper
• Peroxisome Proliferator-activated Receptor α Negatively Regulates the Vascular Inflammatory Gene Response by Negative Cross-talk with Transcription Factors NF-κB and AP-1*

  1999cited by this paper
• H2O2 and Tumor Necrosis Factor-α Induce Differential Binding of the Redox-responsive Transcription Factors AP-1 and NF-κB to the Interleukin-8 Promoter in Endothelial and Epithelial Cells*

  1998cited by this paper
• Prostaglandin D Synthase (β-Trace) in Human Arachnoid and Meningioma Cells: Roles as a Cell Marker or in Cerebrospinal Fluid Absorption, Tumorigenesis, and Calcification Process

  1997cited by this paper
• Endothelial intercellular adhesion molecule-1 expression is suppressed in human malignancies: the role of angiogenic factors.

  1996cited by this paper
• Endothelial-cell proliferation in experimental tumours.

  1982cited by this paper
• Tumor angiogenesis: therapeutic implications.

  1971cited by this paper

• Increased Meflin expression in cancer-associated fibroblasts restrains tumor cell proliferation and shapes vessel-rich stroma in triple-negative breast cancer.

  2026cites this paper
• Impacts of Oxylipins on ischemic stroke: from pathophysiology to clinical phenotypes

  2025cites this paper
• Pan cancer research reveals the role of PTGDS in tumor suppression and immune regulation

  2025cites this paper
• PTGDS deficiency as a driver of M2 macrophage polarization and immunosuppressive microenvironment in esophageal squamous cell carcinoma: an experimental study.

  2025cites this paper
• Biological and prognostic insights into the prostaglandin D2 signaling axis in lung adenocarcinoma

  2025cites this paper
• Ptgds downregulation protect vestibular hair cells from aminoglycoside-induced vestibulotoxicity

  2025cites this paper
• What is the Impact of Endothelial-to-Mesenchymal Transition in Solid Tumours: A Qualitative Systematic Review and Quantitative Meta-Analysis

  2025cites this paper
• Activated T Cells Break Tumor Immunosuppression by Macrophage Reeducation

  2025cites this paper
• Advances in PGD2/PTGDR2 signaling pathway in tumors: A review

  2024cites this paper
• Targeting PTGDS Promotes ferroptosis in peripheral T cell lymphoma through regulating HMOX1-mediated iron metabolism

  2024cites this paper
• The Role of Endothelial L-PGDS in the Pro-Angiogenic and Anti-Inflammatory Effects of Low-Dose Alcohol Consumption

  2024cites this paper
• Diet influences knee osteoarthritis osteophyte formation via gut microbiota and serum metabolites

  2024cites this paper
• Comparison of different estimated glomerular filtration rates for monitoring of kidney function in oncology patients

  2024cites this paper
• Endothelial-to-mesenchymal transition in tumour progression and its potential roles in tumour therapy

  2023cites this paper
• Role of epigenetics and the transcription factor Sp1 in the expression of the D prostanoid receptor 1 in human cartilage

  2023cites this paper
• Proteonano™: a novel deep proteomics platform with 1000-plex profiling capacity and picogram sensitivity and its application in diabetic kidney disease

  2023cites this paper
• Roles of lipocalin-type and hematopoietic prostaglandin D synthases in mouse retinal angiogenesis

  2023cites this paper
• Roles of TGF-β signals in tumor microenvironment via regulation of the formation and plasticity of vascular system.

  2023cites this paper
• PGD2 displays distinct effects in diffuse large B-cell lymphoma depending on different concentrations

  2023cites this paper
• MME+ fibro-adipogenic progenitors are the dominant adipogenic population during fatty infiltration in human skeletal muscle

  2022cites this paper
• MSC-Derived Extracellular Vesicle-Delivered L-PGDS Inhibit Gastric Cancer Progression by Suppressing Cancer Cell Stemness and STAT3 Phosphorylation

  2022cites this paper
• Emerging roles of inflammation-mediated endothelial–mesenchymal transition in health and disease

  2022influential citation
• Single-cell RNA sequencing reveals the existence of pro-metastatic subpopulation within a parental B16 murine melanoma cell line.

  2022cites this paper
• The role of some lipids and their metabolites in programmed cell death (lipoapoptosis).

  2022cites this paper
• Understanding the Role and Prognostic Significance of Prostaglandin D2 Signaling in Lung Adenocarcinoma

  2022cites this paper
• Glycoprotein PTGDS promotes tumorigenesis of diffuse large B-cell lymphoma by MYH9-mediated regulation of Wnt–β-catenin–STAT3 signaling

  2021cites this paper
• Prostaglandin Pathways: Opportunities for Cancer Prevention and Therapy

  2021cites this paper
• Biochemical and Structural Characteristics, Gene Regulation, Physiological, Pathological and Clinical Features of Lipocalin-Type Prostaglandin D2 Synthase as a Multifunctional Lipocalin

  2021cites this paper
• Human placental bed transcriptomic profiling reveals inflammatory activation of endothelial cells in preeclampsia

  2021cites this paper
• Prognostic Value of a Ten-Gene Signature in HNSCC Patients Based on Tumor-Associated Macrophages Expression Profiling

  2020cites this paper
• [A mechanisms of drug resistance in tumor endothelial cells].

  2020cites this paper
• YAP promotes self-renewal of gastric cancer cells by inhibiting expression of L-PTGDS and PTGDR2

  2020cites this paper
• Bioactive lipids, inflammation and chronic diseases.

  2020cites this paper
• Involvement of Metabolic Lipid Mediators in the Regulation of Apoptosis

  2020cites this paper
• Tumour-Infiltrating Immune Cell-Based Subtyping and Signature Gene Analysis in Breast Cancer Based on Gene Expression Profiles

  2020cites this paper
• Therapeutic Potential of Hematopoietic Prostaglandin D2 Synthase in Allergic Inflammation

  2019cites this paper
• Condemned or Not to Die? Gene Polymorphisms Associated With Cell Death in Pemphigus Foliaceus

  2019cites this paper
• Comprehensive Profiling of Primary and Metastatic ccRCC Reveals a High Homology of the Metastases to a Subregion of the Primary Tumour

  2019cites this paper
• Inhibition of microRNA-183 expression resists human umbilical vascular endothelial cells injury by upregulating expression of IRS1

  2019cites this paper
• Physiological Roles of Mast Cells: Collegium Internationale Allergologicum Update 2019

  2019cites this paper
• Anti-apoptotic Regulation Contributes to the Successful Nuclear Reprogramming Using Cryopreserved Oocytes

  2019cites this paper
• Update on the human and mouse lipocalin (LCN) gene family, including evidence the mouse Mup cluster is result of an “evolutionary bloom”

  2019cites this paper
• Interleukin-13 receptor α2 is a novel marker and potential therapeutic target for human melanoma

  2019cites this paper
• Tumor microenvironment: Interactions and therapy

  2018cites this paper
• Gene expression profiles analysis identifies a novel two-gene signature to predict overall survival in diffuse large B-cell lymphoma

  2018cites this paper
• Role of prostaglandins in tumor microenvironment

  2018cites this paper
• EndMT: A promising and controversial field.

  2018cites this paper